Could you Afterpay a dinner date one day?

Will buy-now-pay-later become a services sector staple?

a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Afterpay Touch Group Ltd (ASX: APT) share price is up 0.6% on a day when the broader S&P/ ASX200 (ASX: XJO) has shed 1.4% on the back of weak manufacturing data out of the US suggesting it's being hurt by its trade dispute with China. 

Afterpay has not released any specific news to the market today, but has enjoyed a couple of fawning broker ratings from Goldman Sachs and Bell Potter over the last month , both of whom slapped $42.90 and $41.61 price targets on the business respectively.

Both capital markets middle men have also earned capital raising or advisory fees from Afterpay in the past and will be shopping around for more work going forward. 

In fairness Afterpay's blockbuster growth speaks for itself and today's valuation will be justified if it succeeds in stitching up the giant US and UK buy-now-pay-later markets. 

Recently it launched its UK doppelgänger Clearpay in what's a competitive market with well funded rivals including Klarna that reportedly has millennial stalwarts like TopShop, ASOS, and JD Sports already signed up.

Some retailers like JD Sports will offer multiple spread payment options as far as I know. 

This week Clearpay announced that FootLocker has gone live in the UK and Clearpay reportedly clocked more than 200,000 active customers in its first 15 weeks trading in the UK.

Notably, this is more than the runaway train US business at the same-time post launch.

Competition threatening margins appears to be the main risk for Afterpay, but markets as large as the US and UK are not winner takes all.

In other words there should be room for a couple of successful players given the potential size of the markets once you account for the potential of the buy-now-pay-later sector to branch out horizontally across services businesses (flights, dentists, painters, even dinner dates at restaurants,etc) on top of physical retail. 

The stock may have room to climb higher yet.

Tom Richardson owns shares of AFTERPAY T FPO.

You can find Tom on Twitter @tommyr345

The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of AFTERPAY T FPO. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

A man in a suit smiles at the yellow piggy bank he holds in his hand.
Share Market News

Forget Westpac shares, these ASX ETFs could be better buys

Here's why these funds could be quality picks for investors looking for alternatives to the banks.

Read more »

A male investor wearing a white shirt and blue suit jacket sits at his desk looking at his laptop with his hands to his chin, waiting in anticipation.
Share Gainers

Here are the top 10 ASX 200 shares today

It was another tough day for investors.

Read more »

Rising real estate share price.
REITs

Macquarie names its top 4 ASX REITs to buy today

Macquarie expects these four dividend paying ASX REITs will all surge higher in 2026.

Read more »

A doctor or medical expert in COVID protection adjusts her glasses, indicating growth or strong share price movement in ASX medical, biotech and health companies
Opinions

Forget CSL shares, I'd buy this booming biotech stock instead

This ASX biotech stock has caught my eye this year.

Read more »

Man with virtual white circles on his eye and AI written on top, symbolising artificial intelligence.
Broker Notes

Why this ASX AI stock could return 40% in 2026

Let's see which stock Bell Potter is tipping to rise strongly.

Read more »

A medical researcher rests his forehead on his fist with a dejected look on his face while sitting behind a scientific microscope with another researcher's hand on his shoulder as if giving comfort.
Healthcare Shares

Telix Pharmaceuticals shares crash 58% from their peak: Buying opportunity or time to sell up?

The biopharmaceutical company's shares are tipped to soar next year.

Read more »

Red buy button on an apple keyboard with a finger on it representing asx tech shares to buy today
Share Market News

Analysts name 2 top ASX 200 shares to buy today

Leading investment experts name two quality ASX 200 shares to buy now.

Read more »

Woman leaping in the air and standing out from her friends who are watching.
Broker Notes

This ASX 200 gold stock has surged 77% in 2025. Here's why Macquarie expects it to leap another 23%

Macquarie forecasts 23% upside for this surging ASX gold stock, and that doesn’t include the dividends!

Read more »